source
- Goa Therapeutics launches with $15.5M funding to develop fast-acting alcohol sobering drugGoa Therapeutics announced its launch, backed by $15.5 million raised mainly from individual industry leaders, and has filed for an initial public offering that could raise up to $75 million. The…
- Biotech hedge fund launches North Immunology to develop long-acting antibody for atopic dermatitisSTAT+ hedge fund is creating a new immunology company called North Immunology with the goal of delivering a better, long-acting antibody therapy for atopic dermatitis. The concept originated two y…